Int J Radiat Oncol Biol Phys 2024 Nov 1;120(3):615-620. doi: 10.1016/j.ijrobp.2024.07.2321. Epub 2024 Sep 24. https://pubmed.ncbi.nlm.nih.gov/39326944/
Abstract: Background: Pediatric and young adult patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) face a crucial, yet understudied, risk
Abstract Cytomegalovirus (CMV) infection is a major complication of hematopoietic stem cell transplantation (HSCT). Previous studies in adults demonstrated that
Abstract Measurable residual disease (MRD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an independent risk factor for relapse in
Christoph Röllig and Gerhard Ehninger,
Blood 2015 :blood-2014-10-551507
Deepa Bhojwani, MD, Jun J. Yang, PhD, Ching-Hon Pui, MD, Pediatric clinics of North America, Vol: 62, Issue: 1,
Deepa Bhojwani, MD, Jun J. Yang, PhD, Ching-Hon Pui, MD, Pediatric clinics of North America, Vol: 62, Issue: 1,
Deepa Bhojwani, MD, Jun J. Yang, PhD, Ching-Hon Pui, MD, Pediatric clinics of North America, Vol: 62, Issue: 1,
Abstract Purpose: Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical
Abstract Background Suffering at the end-of-life (EOL) can impact the perception of a “good death” and ultimately affect bereavement for
נותנות החסות לאיגוד:
הכניסה לאתר מותרת אך ורק לרופאים/ות בעלי רישיון לעסוק ברפואה בישראל
ו/או בעלי רישיון לעסוק ברוקחות ו/או אדם הנמנה על צוות רפואי או מחקר ביו-רפואי.